Capital Markets

Latest Stories

BlackRock to Offer Space ETF That Will Add New IPOs Within Days

BlackRock Inc. is launching a new space ETF for European investors that will add newly listed companies within 10 to 30 days.

By Leonard Kehnscherper

Elon Musk Shows Detailed Design of AI Data Center Satellite

Elon Musk unveiled a more detailed look at an initial version of an AI data center satellite SpaceX plans to build, providing fresh insight into the ambitious project driving the company’s highly anticipated initial public offering.

SpaceX IPO Is Well Oversubscribed With $10 Billion Orders

SpaceX’s initial public offering is well oversubscribed with multiple institutional investors placing orders for about $10 billion or more of shares, according to people familiar with the matter, as demand builds for a potentially record-setting debut.

NY Knicks Success a Win for Lenders Who Propped Up Broadcaster

Just a year before the New York Knicks rode a double-digit winning streak to the NBA Finals, the company that broadcasts its games was thrown a lifeline to avoid a potential bankruptcy filing. Now, the lenders who backed that restructuring are likely cheering on the team’s success.

OpenAI Files Confidentially for IPO as Rivals Compete for Cash

OpenAI, the maker of ChatGPT, filed confidentially for an IPO, joining artificial intelligence rivals in tapping public markets to fund ambitious growth plans.

Bitcoin’s $235 Billion Crash Masks Bigger Shift in Crypto

The easiest way to understand crypto used to be to look at Bitcoin.

SpaceX IPO Forces Investors to Bet on Musk’s Entangled AI Empire

The boundaries between Elon Musk’s companies are growing increasingly blurred through shared capital, talent and infrastructure. Investors must decide what that ecosystem is worth.

AI Misuse Claims in FTX Litigation Roil Fight Over Settlement

Lawyers in court battles over FTX’s collapse are accusing attorneys for one group of plaintiffs of filing a legal brief with AI-generated hallucinations.

Astra Obesity Pill Delivers 11.8% Weight Loss in Mid-Stage Trial

AstraZeneca Plc’s experimental obesity pill helped patients lose as much as 11.8% of their body weight in a mid-stage trial, as the British drugmaker pushes into the surging market for weight-loss combination drugs.

Brightline West Moves Ahead With New Infrastructure Contracts

High-speed railway Brightline West has signed new contracts to lay tracks and systems for its high-speed railway, according to an email seen by Bloomberg, signaling progress for a project whose municipal bonds have traded at steep discounts since last year.